Assignee
HOOKIPA BIOTECH GMBH
AT·6 granted patents·14 pending applications·30 citations·filing 2014–2024
Top patents by PatentIndex Score
20 records- 0189US10669315B2HPV vaccinesHOOKIPA BIOTECH GMBH·Filed 2016·Granted Jun 2, 2020·7 cites·52 claims
- 0288US11214598B2Vaccines against hepatitis B virusHOOKIPA BIOTECH GMBH·Filed 2016·Granted Jan 4, 2022·4 cites·34 claims
- 0387US11266727B2Arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2016·Granted Mar 8, 2022·4 cites·26 claims
- 0485US10111945B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2014·Granted Oct 30, 2018·13 cites·29 claims
- 0579US11407790B2HPV vaccinesHOOKIPA BIOTECH GMBH·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 0678US11554169B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2018·Granted Jan 17, 2023·1 cites·55 claims
- 0772US2025009860A1Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2024·Application pending·0 cites
- 0872US2023181725A1Cmv vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0969US2023086859A1Hpv vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1065US2022289797A1Tri-segmented pichinde viruses as vaccine vectorsHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1163US2022073568A1Vaccines against hepatitis b virusHOOKIPA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1261US2022257734A1Arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1361US2025057931A1Combination therapy with arenavirus particles and immune checkpoint modulators or cytokinesHOOKIPA BIOTECH GMBH·Filed 2023·Application pending·0 cites
- 1459US2025073324A1Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapiesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1559US2024229073A1Arenaviruses as vectorsHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1656US2024174724A1Arenaviruses used in treatments of prostate cancerHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1754US2020206334A1Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2017·Application pending·0 cites
- 1849US2023346906A1Cancer treatment strategies using arenavirus vectorsHOOKIPA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1945US2020113995A1Arenavirus particles to treat solid tumorsHOOKIPA BIOTECH GMBH·Filed 2018·Application pending·0 cites
- 2044US2019135875A1Tri-segmented pichinde viruses as vaccine vectorsHOOKIPA BIOTECH GMBH·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →